€
G. Turkmen et al. / Tetrahedron 71 (2015) 4770e4778
4775
2-aminomethylpiperidine, Pd(OAc)2 were obtained from Alfa Aesar
and solvents like dichloromethane, acetonitrile, ethanol, diethyl
ether, toluene, pyridine were obtained from Merck and Ridel de
Haen. The compound A8a and salts (1b, 1c)11 were prepared
according to literature procedure. Elemental analysis data were
recorded with CHNS Elemental Analysis. 1H NMR and 13C NMR
spectra were recorded on a Varian AS 400 Mercury instrument. As
solvents CDCl3 was employed. FTIR spectra were recorded on
a Perkin Elmer Spectrum 100 series.
d
¼178.9 (Ccarbene), 152.6 (Py-C), 139.3, 138.9 (NCH2C6H(CH3)3CH2N),
137.9 (Py-C), 130.9, 130.0 (NCH2C6H(CH3)3CH2N), 124.6 (Py-C), 59.4
(NCH2CH), 54.4 (NCH2C6H(CH3)3CH2N), 49.3, 49.2, 32.1, 25.6, 23.3
(piperidine-C), 21.3, 17.8 (NCH2C6H(CH3)3CH2N). IR, ʋmax (CH2Cl2):
3054, 2987, 2947, 2861, 2370, 2308, 1605, 1448, 1308, 1266, 1071,
687 cmꢁ1. Anal. Calcd for C35H46Br4N6Pd2 (M¼1083.24): C, 38.81; H,
4.28; N, 7.76; Found C, 38.61; H, 4.29; N, 7.62%.
4.1.4. Compound 2b. This complex was prepared by same method
as for 2a starting from 1b (298.3 mg, 0.5 mmol) and Pd(OAc)2
(224.5 mg, 1.0 mmol). Yield: 355 mg, 63%, mp¼285e286 ꢀC. 1H
NMR (400 MHz, CDCl3, TMS, 25 ꢀC, ppm): 9.06 (d, J¼5.2 Hz, 4H,
Py-Ho), 7.76e7.70 (m, 2H, Py-Hp), 7.38e7.29 (m, 4H, Py-Hm), 7,03
4.1.1. Compound 1b. The salt (1b) was prepared according to the
literature procedure.11 2,4-bis(bromomethyl)-1,3,5-triethyl benzene
(348 mg, 1.0 mmol), 1,5,6,7,8,8a-hexahydroimidazo[1,5-a]pyridine
(248 mg, 2.0 mmol) were refluxed in toluene (10.0 mL) for 4 h. The
volume of the solution was reduced to 5 mL under vacuum. Diethyl
ether was added to the solution and vigorously shaken and then
decanted. The solid residue was washed with diethyl ether. Yield:
578 mg, 97%, mp¼175e176 ꢀC.1H NMR (400 MHz, CDCl3, TMS, 25 ꢀC,
(s,
1H,
NCH2C6H(CH2CH3)3CH2N),
5.40e5.36
(m,
4H,
NCH2C6H(CH2CH3)3CH2N), 5.13e5.09 (m, 2H, piperidine-H),
3.69e3.64 (m, 2H, piperidine-H), 3.35e3.26 (m, 4H, NCH2CH),
2.98e2.86 (m, 2H, piperidine-H), 2.79e2.75 (m, 6H,
NCH2C6H(CH2CH3)3CH2N), 1.95e1.87 (m, 4H, piperidine-H),
1.80e1.73 (m, 4H, piperidine-H), 1.46e1.40 (m, 4H, piperidine-H)
1.38e1.23 (m, 9H, NCH2C6H(CH2CH3)3CH2N). 13C NMR (100.6 MHz,
ppm):
d
¼9.07 (s, 2H, NCHN), 7.06 (s, 1H, NCH2C6H(CH2CH3)3CH2N),
4.54e4.20 (m, 6H, NCH2C6H(CH2CH3)3CH2N, piperidine-H),
3.76e3,72 (m, 2H, NCH2), 3.72e3,66 (m, 2H, NCH2), 3.41e3,37 (m,
2H, piperidine-H), 2.69e2.65 (m, 2H, CH2CH3), 2.56e2.48 (m, 4H,
CH2CH3), 2.09e2,05 (m, 4H, piperidine-H), 1.78e1.73 (m, 4H, piper-
idine-H),1.64e1.50 (m, 6H, piperidine-H),1.20e1,16 (m, 9H, CH2CH3).
CDCl3, TMS, 25 ꢀC, ppm):
139.0 (NCH2C6H(CH2CH3)3CH2N), 138.1 (Py-C), 128.5, 128.4
(NCH2C6H(CH2CH3)3CH2N), 124.6 (Py-C), 59.6 (NCH2CH), 54.2
(NCH2C6H(CH2CH3)3CH2N), 48.5, 48.0, 32.0, 26.7, 25.6 (piperidine-
d¼179.0 (Ccarbene), 154.5 (Py-C), 139.6,
13C NMR (100.6 MHz, CDCl3, TMS, 25 ꢀC, ppm):
d¼154.3 (NCHN),
C),
23.3,
23.1
(NCH2C6H(CH2CH3)3CH2N),
16.3,
15.6
145.9, 137.7, 128.9, 125.9 (NCH2C6H2(CH(CH3)2)2CH2N), 59.8
(NCH2CH), 55.9 (NCH2C6H2(CH(CH3)2)2CH2N), 45.9, 31.7, 26.0, 25.5,
24.0 (piperidine-C), 22.1 (CH2eCH3), 16.7 (CH2eCH3). Anal. Calcd for
(NCH2C6H(CH2CH3)3CH2N). IR, ʋmax (CH2Cl2): 3055, 2987, 2685,
2306, 1605, 1521, 1448, 1422, 1285, 1071, 771 cmꢁ1. Anal. Calcd for
C
38H52Br4N6Pd2 (M¼1125.32): C, 40.56; H, 4.66; N, 7.47; Found C,
C
28H44Br2N4 (M¼596.48): C, 56.38; H, 7.44; N, 9.39; Found C, 56.45;
40.84; H, 4.96; N, 7.58%.
H, 7.57; N, 9.32%.
4.1.5. Compound 2c. This complex was prepared by same method
as for 2a starting from 1c (298.3 mg, 0.5 mmol) and Pd(OAc)2
(224.5 mg, 1.0 mmol). Yield: 366 mg, 65%, mp¼288e289 ꢀC. 1H
4.1.2. Compound 1c. This complex was prepared by same method
as for 1b11 starting from 2,4-bis(bromomethyl)-1,3,5-triisopropyl
benzene (348 mg, 1 mmol), 1,5,6,7,8,8a-hexahydroimidazo[1,5-a]
pyridine (248 mg, 2.0 mmol). Yield: 525 mg, 88%; mp¼171e172 ꢀC.
NMR (400 MHz, CDCl3, TMS, 25 ꢀC, ppm):
d
¼8.98 (d, J¼7.6 Hz, 4H,
Py-Ho), 7.71 (t, J¼7.6 Hz, 2H, Py-Hp), 7.75e6.67 (m, 6H, Py-Hm,
1H NMR (400 MHz, CDCl3, TMS, 25 ꢀC, ppm):
d¼9.52 (s, 2H, NCHN),
NCH2C6H2(CH(CH3)2)2CH2N), 5.62 (d, Hz, 1H,
J¼3.9
7.56 (s, 1H, NCH2C6H2(CH(CH3)2)2CH2N), 7.21 (s, 1H,
NCH2C6H2(CH(CH3)2)2CH2N), 5.11, 4.75 (d, J¼14.8 Hz, 4H,
NCH2C6H2(CH(CH3)2)2CH2N), 4.49e4.45 (m, 2H, piperidine-H),
4.38e4.34 (m, 4H, NCH2), 3.85e3.80 (m, 2H, piperidine-H),
3.05e3.02 (m, 2H, CH(CH3)2), 2.04e1.92 (m, 4H, piperidine-H),
1.63e1.55 (m, 4H, piperidine-H), 1.57e1.52 (m, 12H, piperidine-H),
1.21e1.14 (m, 6H, CH(CH3)2). 13C NMR (100.6 MHz, CDCl3,
NCH2C6H2(CH(CH3)2)2CH2N), 5.42 (d, J¼3.9 Hz,1H, Ph-CH2), 5.20 (d,
J¼3.9 Hz, 1H, NCH2C6H2(CH(CH3)2)2CH2N), 5.10e5.06 (m, 2H, pi-
peridine-H), 5.02 (d, J¼3.9 Hz, 1H, NCH2C6H2(CH(CH3)2)2CH2N),
3.92e3.84 (m, 2H, NCH2CH), 3.71e3.66 (m, 4H, NCH2CH),
3.46e3.40 (m, 2H, piperidine-H), 3.34e3.27 (m, 2H,
NCH2C6H2(CH(CH3)2)2CH2N), 3.25e3.18 (m, 2H, piperidine-H),
3.03e2.98 (m, 2H, piperidine-H), 1.94e1.90 (m, 4H, piperidine-H),
1.78e1.72 (m, 4H, piperidine-H), 1.48e1.44 (m, 4H, piperidine-H),
1.29e1.22 (m, 12H, NCH2C6H2(CH(CH3)2)2CH2N). 13C NMR
TMS, 25 ꢀC, ppm):
d
¼155.7 (NCHN), 148.2, 130.9, 127.8,
123.4 (NCH2C6H2(CH(CH3)2)2CH2N), 59.6 (NCH2CH), 54.6,
(NCH2C6H2(CH(CH3)2)2CH2N), 48.1, 45.9, 31.5, 28.9, 25.4, (piperi-
dine-C), 23.9 (CH(CH3)2), 22.1 (CH(CH3)2). Anal. Calcd for
(100.6 MHz, CDCl3, TMS, 25 ꢀC, ppm):
d
¼178.2, 177.9 (Ccarbene),
153.3, 151.4 (Py-C), 146.1, 145.8 (NCH2C6H2(CH(CH3)2)2CH2N), 137.3,
136.7 (Py-C),128.5,128.4,127.8,127.3 (NCH2C6H2(CH(CH3)2)2CH2N),
123.9, 123.4, 121.7, 121.6 (Py-C), 59.1, 59.0 (NCH2CH), 53.9, 53.8
(NCH2C6H2(CH(CH3)2)2CH2N), 50.9, 50.7 (piperidine-C), 47.2, 46.8
(NCH2C6H2(CH(CH3)2)2CH2N), 31.0, 30.9, 27.5, 27.3 24.4,
24.3, 23.0, 22.9, 22.8, 22.7, 22.2, 22.1 (piperidine-C,
NCH2C6H2(CH(CH3)2)2CH2N). IR, ʋmax (CH2Cl2): 3054, 2987, 2686,
2306, 1605, 1520, 1448, 1422, 1263, 773 cmꢁ1. Anal. Calcd for
C
28H44Br2N4 (M¼596.48): C, 56.38; H, 7.44; N, 9.39; Found C, 56.21;
H, 7.49; N, 9.31%.
4.1.3. Compound 2a. A schlenk tube was charged with Pd(OAc)2
(224.5 mg, 1.0 mmol), KBr (238.0 mg, 2.0 mmol), 1a (277.2 mg,
0.5 mmol). Pyridine (5.0 mL) was then added as the solvent. It was
heated at 90 ꢀC during 24 h. During this time, the reaction solution
turned orange from being initially red. The remaining pyridine was
removed in vacuo to give an orange solid. Further purification was
carried out using flash column (CH2Cl2) to get pure complexes for
analysis and catalysis. Yield: 368 mg, 68%, mp¼281e282 ꢀC. 1H NMR
C
38H52Br4N6Pd2 (M¼1125.32): C, 40.56; H, 4.66; N, 7.47; Found C,
40.67; H, 4.48; N, 7.30%.
4.1.6. Compound 2d. This complex was prepared by same method
as for 2a starting from 1d (284.2 mg, 0.5 mmol) and Pd(OAc)2
(224.5 mg, 1.0 mmol). Yield: 395 mg, 70%, mp¼275e276 ꢀC. 1H
(400 MHz, CDCl3, TMS, 25 ꢀC, ppm):
d¼9.05 (d, J¼5.2 Hz, 4H, Py-Ho),
7.74 (t, J¼5.2 Hz, 2H, Py-Hp), 7.32 (t, J¼5.2 Hz, 4H, Py-Hm), 6.95 (s,1H,
NCH2C6H(CH3)3CH2N), 5.31 (s, 4H, NCH2C6H(CH3)3CH2N), 5.10e5.07
(m, 2H, piperidine-H), 3.71e3.69 (m, 2H, piperidine-H), 3.32e3.30
(m, 4H, NCH2CH), 2.78e2.76 (m, 2H, piperidine-H), 2.55 (s, 3H,
NCH2C6H(CH3)3CH2N), 2.44 (s, 6H, NCH2C6H(CH3)3CH2N), 1.97e1.92
(m, 4H, piperidine-H),1.79e1.73 (m, 4H, piperidine-H),1.47e1.39 (m,
4H, piperidine-H). 13C NMR (100.6 MHz, CDCl3, TMS, 25 ꢀC, ppm):
NMR (400 MHz, CDCl3, TMS, 25 ꢀC, ppm):
d
¼9.02 (d, J¼5.1 Hz, 4H,
Py-Ho), 7.72 (t, J¼5.1 Hz, 2H, Py-Hp), 7.34 (t, J¼5.1 Hz, 4H, Py-Hm),
5.38e5.26 (m, 4H, NCH2C6 (CH3)4CH2N), 5.10e5.07 (m, 2H, piperi-
dine-H), 3.70e3.66 (m, 2H, piperidine-H), 3.34e3.23 (m, 4H,
NCH2CH), 2.81e2.77 (m, 2H, piperidine-H), 2.37 (s, 12H, NCH2C6
(CH3)4CH2N), 1.98e1.94 (m, 4H, piperidine-H), 1.79e1.72 (m, 4H,